Claudia Gerken

Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · Journal of Clinical Oncology · 2015 · 979 citations

Medicine, Immunology, Oncology +17

HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde et al. · JAMA Oncology · 2017 · 837 citations · Full text

Medicine, Immunology, Oncology +17

Adoptive Transfer of EBV-specific T Cells Results in Sustained Clinical Responses in Patients With Locoregional Nasopharyngeal Carcinoma

Chrystal U. Louis, Karin Straathof, Catherine M. Bollard et al. · Journal of Immunotherapy · 2010 · 223 citations · Full text

Life Sciences, Immunology, Oncology +17

Inducible Activation of MyD88 and CD40 in CAR T Cells Results in Controllable and Potent Antitumor Activity in Preclinical Solid Tumor Models

Melinda Mata, Claudia Gerken, Phuong Nguyen et al. · Cancer Discovery · 2017 · 176 citations · Full text

Life Sciences, Immunology, Oncology +17

Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

Meenakshi Hegde, Sujith K. Joseph, Farzana Pashankar et al. · Nature Communications · 2020 · 167 citations · Full text

Life Sciences, Immunology, Oncology +16